{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:52:34Z","timestamp":1791078754234,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.bone.2004.06.001","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T01:37:42Z","timestamp":1091151462000},"page":"859-869","source":"Crossref","is-referenced-by-count":41,"title":["Long-term effects of neridronate on human osteoblastic cell cultures"],"prefix":"10.1016","volume":"35","author":[{"given":"Bruno","family":"Frediani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Spreafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Capperucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Chellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Gambera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ferrata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Falsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Marcolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2004.06.001_BIB1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/er.19.1.80","article-title":"Bisphosphonates: mechanisms of action","volume":"19","author":"Fleisch","year":"1998","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.bone.2004.06.001_BIB2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pharmtox.38.1.375","article-title":"Mechanisms of action of bisphosphonates","volume":"38","author":"Rodan","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"10.1016\/j.bone.2004.06.001_BIB3","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","article-title":"Bisphosphonates act on rat bone resorption through the mediation of osteoblasts","volume":"91","author":"Sahni","year":"1993","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.bone.2004.06.001_BIB4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S8756-3282(98)00033-7","article-title":"Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo","volume":"22","author":"Giuliani","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.06.001_BIB5","first-page":"6001","article-title":"Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts","volume":"60","author":"Reinholz","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2004.06.001_BIB6","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1359\/jbmr.2001.16.11.2050","article-title":"Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro","volume":"16","author":"Mathov","year":"2001","journal-title":"J. Bone Miner. Res"},{"key":"10.1016\/j.bone.2004.06.001_BIB7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S8756-3282(01)00615-9","article-title":"Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis","volume":"29","author":"Halasy-Nagy","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.06.001_BIB8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S8756-3282(01)00485-9","article-title":"Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women","volume":"29","author":"Roschger","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.06.001_BIB9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","article-title":"Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts","volume":"291","author":"Viereck","year":"2002","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.bone.2004.06.001_BIB10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.96.1.133","article-title":"Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro","volume":"96","author":"Fisher","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bone.2004.06.001_BIB11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0026-0495(89)90260-6","article-title":"Diphosphonates inhibit human osteoblast secretion and proliferation","volume":"38","author":"Khokher","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/j.bone.2004.06.001_BIB12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1097-4644(19980201)68:2<186::AID-JCB5>3.0.CO;2-R","article-title":"Structurally different bisphosphonates exert opposing effects on alkaline phosphatase and mineralization in marrow osteoprogenitors","volume":"68","author":"Klein","year":"1998","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.bone.2004.06.001_BIB13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1042\/bj1830073","article-title":"Increase in alkaline phosphatase activity in calvaria cells cultured with diphosphonates","volume":"183","author":"Felix","year":"1979","journal-title":"J. Biochem"},{"key":"10.1016\/j.bone.2004.06.001_BIB14","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1210\/en.137.6.2324","article-title":"Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption","volume":"137","author":"Vitte","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2004.06.001_BIB15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S8756-3282(97)00270-6","article-title":"Effect of alendronate on cultured normal human osteoblasts","volume":"22","author":"Garcia-Moreno","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.06.001_BIB16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF03345497","article-title":"Bisphosphonates influences the proliferation and the maturation of normal human osteoblasts","volume":"25","author":"Fromigu\u00e9","year":"2002","journal-title":"J. Endocrinol. Invest"},{"issue":"2","key":"10.1016\/j.bone.2004.06.001_BIB17","first-page":"85","article-title":"Gene expression in osteoblastic cells","volume":"1","author":"Rodan","year":"1991","journal-title":"Crit. Rev. Eukaryot. Gene Expr"},{"issue":"1","key":"10.1016\/j.bone.2004.06.001_BIB18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/030097498441155","article-title":"Bisphosphonates inhibit IL-6 production by human osteoblast-like cells","volume":"27","author":"Giuliani","year":"1998","journal-title":"Scand. J. Rheumatol"},{"key":"10.1016\/j.bone.2004.06.001_BIB19","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.biomaterials.2003.11.024","article-title":"Osteoblast proliferation and maturation by bisphosphonates","volume":"25","author":"Im","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2004.06.001_BIB20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s11626-997-0154-7","article-title":"Characterization of human osteoblastic cells: influence of the culture conditions","volume":"33","author":"Rattner","year":"1997","journal-title":"In Vitro Cell. Dev. Biol. Anim"},{"key":"10.1016\/j.bone.2004.06.001_BIB21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1359\/jbmr.2003.18.1.126","article-title":"Intravenous neridronate in adults with osteogenesis imperfecta","volume":"18","author":"Adami","year":"2003","journal-title":"J. Bone Miner. Res"},{"issue":"3","key":"10.1016\/j.bone.2004.06.001_BIB22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S8756-3282(03)00084-X","article-title":"Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis","volume":"33","author":"Braga","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.06.001_BIB23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/004982597240442","article-title":"Drug disposition of incadronate, a new bisphosphonate in rats with bone metastases","volume":"27","author":"Usui","year":"1997","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bone.2004.06.001_BIB24","first-page":"323","article-title":"Osteoblast behaviour in the presence of bisphosphonates: ultrastructural and biochemical in vitro studies","volume":"17","author":"Gandolfi","year":"1999","journal-title":"Clin. Exp. Rheumatol"},{"key":"10.1016\/j.bone.2004.06.001_BIB25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00003088-199936050-00002","article-title":"Pharmacokinetics of alendronate","volume":"36","author":"Porras","year":"1999","journal-title":"Clin. Pharmacokinet"},{"key":"10.1016\/j.bone.2004.06.001_BIB26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jbmr.5650100106","article-title":"Expression and secretion of parathyroid hormone-related protein by human bone-derived cells in vitro: effects of glucocorticoids","volume":"10","author":"Walsh","year":"1995","journal-title":"J. Bone Miner. Res"},{"key":"10.1016\/j.bone.2004.06.001_BIB27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s002239900217","article-title":"Ultrastructure and cytochemical detection of alkaline phosphatase in long-term cultures of osteoblast-like cells from rat calvaria","volume":"60","author":"Herbert","year":"1997","journal-title":"Calcif. Tissue Int"},{"key":"10.1016\/j.bone.2004.06.001_BIB28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple non radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H] thymidine incorporation assay","volume":"170","author":"Ahmed","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bone.2004.06.001_BIB29","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/en.141.11.3956","article-title":"Inhibition of osteoblast differentiation by tumor necrosis factor-\u03b1","volume":"141","author":"Gilbert","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2004.06.001_BIB30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/000164701753542069","article-title":"Enhancement of human osteoblast proliferation and phenotypic expression when cultured in human serum","volume":"72","author":"Hankey","year":"2001","journal-title":"Acta Orthop. Scand"},{"key":"10.1016\/j.bone.2004.06.001_BIB31","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bone.2004.06.001_BIB32","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1210\/en.142.7.2731","article-title":"Minireview: transcriptional control of osteoblast differentiation","volume":"142","author":"Karsenty","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2004.06.001_BIB33","series-title":"Human cell culture protocols","first-page":"233","article-title":"Isolation and culture of bone-forming cells (osteoblast) from human bone","author":"Gallagher","year":"1996"},{"key":"10.1016\/j.bone.2004.06.001_BIB34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K","article-title":"Proliferation and differentiation rates of human osteoblast-like cell line (SaOS-2) in contact with different bone substitute materials","volume":"57","author":"Mayr-Wohlfart","year":"2001","journal-title":"J. Biomed. Mater. Res"},{"key":"10.1016\/j.bone.2004.06.001_BIB35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/jcb.1270","article-title":"Cellular and molecular properties associated with osteosarcoma cells","volume":"84","author":"Benayahu","year":"2002","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.bone.2004.06.001_BIB36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.0.CO;2-6","article-title":"Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation","volume":"75","author":"Siggelkow","year":"1999","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.bone.2004.06.001_BIB37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0753-3322(02)00329-3","article-title":"Comparative interspecies investigation on osteoblast cultures: data on cell viability and synthetic activity","volume":"57","author":"Torricelli","year":"2003","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.bone.2004.06.001_BIB38","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0022-4731(89)90416-0","article-title":"Mouse embryo fibroblast proliferation and prostaglandin production in Medium supplemented with fetal bovine serum or serum substitutes (Ultroser SF and G): role of glucocorticoids","volume":"33","author":"Durant","year":"1989","journal-title":"J. Steroid Biochem"},{"key":"10.1016\/j.bone.2004.06.001_BIB39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1432-1033.1990.tb15382.x","article-title":"Mechanism of glucocorticoid regulation of alkaline phosphatase gene expression in osteoblast-like cell","volume":"188","author":"Green","year":"1990","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.bone.2004.06.001_BIB40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jbmr.5650050803","article-title":"Long term effects of physiologic concentration of dexamethasone on human bone derived cells","volume":"5","author":"Wong","year":"1990","journal-title":"J. Bone Miner. Res"},{"key":"10.1016\/j.bone.2004.06.001_BIB41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1432-1033.1995.0183i.x","article-title":"Glucocorticoid regulation of bone sialoprotein (BSP) gene expression identification of a glucocorticoid response element in a bone sialoprotein gene promoter","volume":"230","author":"Ogata","year":"1995","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.bone.2004.06.001_BIB42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/rheumatology\/40.1.74","article-title":"High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis","volume":"40","author":"Walsh","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bone.2004.06.001_BIB43","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure","volume":"88","author":"Sato","year":"1991","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.bone.2004.06.001_BIB44","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"14","article-title":"Bone formation: osteoblast lineage cells, growth factors, matrix proteins, and the mineralization process","author":"Lian","year":"1999"},{"key":"10.1016\/j.bone.2004.06.001_BIB45","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.bone.2004.06.001_BIB46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1254\/jjp.86.86","article-title":"Incadronate and etidronate accelerate phosphate-primed mineralization of MC4 cells via ERK1\/2-Cbfa1 signaling pathway in a Ras-independent manner: further involvement of mevalonate-pathway blockade for incadronate","volume":"86","author":"Fujita","year":"2001","journal-title":"Jpn. J. Pharmacol"},{"key":"10.1016\/j.bone.2004.06.001_BIB47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1254\/jjp.66.25","article-title":"Alendronate modulates osteogenesis of human osteoblastic cells in vitro","volume":"66","author":"Tsuchimoto","year":"1994","journal-title":"Jpn. J. Pharmacol"},{"key":"10.1016\/j.bone.2004.06.001_BIB48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bone.2003.08.013","article-title":"The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro","volume":"34","author":"Pan","year":"2004","journal-title":"Bone"},{"issue":"15","key":"10.1016\/j.bone.2004.06.001_BIB49","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI119668","article-title":"Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis","volume":"100","author":"Chavassieux","year":"1997","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.bone.2004.06.001_BIB50","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1359\/jbmr.2000.15.4.754","article-title":"Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies","volume":"15","author":"Chavassieux","year":"2000","journal-title":"J. Bone Miner. Res"},{"key":"10.1016\/j.bone.2004.06.001_BIB51","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","article-title":"Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women","volume":"27","author":"Boivin","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2004.06.001_BIB52","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1210\/jc.80.12.3465","article-title":"Skeletal metabolism in patients with osteoporosis after discontinuation of long-term treatment with oral pamidronate","volume":"80","author":"Landman","year":"1995","journal-title":"J. Clin. Endocrinol. Metab"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204002510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328204002510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T04:26:31Z","timestamp":1549340791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328204002510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S8756328204002510"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2004.06.001","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}